search for



KCI

Crossref

Cross mark

Cited-by

Fundref

TDM

View (198) Download (117) CrossRef (1)
Effective Smoking Cessation Counseling for Participants in a Lung Cancer Screening
J Korean Soc Res Nicotine Tob 2024; 15(3): 88-95
Published online September 30, 2024
© 2024 The Korean Society for Research on Nicotine and Tobacco.

Choon-Young Kim1, Yeol Kim2, Cheol Min Lee1,3*

1Department of Family Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, 2Division of Cancer Early Detection, National Cancer Control Institute, National Cancer Center, Goyang, 3Department of Family Medicine, Seoul National University College of Medicine, Seoul, Korea
Correspondence to: *이철민
서울대학교 의과대학 가정의학교실
E-mail: bigbangx@snuh.org
ORCID: https://orcid.org/0000-0001-8652-4355
Received September 23, 2024; Revised September 28, 2024; Accepted September 29, 2024.
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.
 Abstract
Since 2019, lung cancer screening using low-dose chest computed tomography (LDCT) has been implemented for high-risk smokers as part of Korea’s national cancer screening program. Smoking is the leading cause of lung cancer, and smoking cessation is crucial for reducing the disease’s incidence and mortality rates. After lung cancer screening, the consulting physician should offer participants a thorough consultation on the LDCT results, along with comprehensive smoking cessation counseling. However, this counseling is often inadequately addressed. The consulting physician should help participants understand the risks associated with smoking and clearly explain the benefits of quitting. For smokers who have previously struggled with quitting, fostering a positive outlook and avoiding the attribution of their challenges solely to a lack of willpower is critical. It is essential to encourage quitting through a combination of medication and counseling. When time or expertise for smoking cessation counseling is limited, referring patients to national smoking cessation resources—such as public health center clinics, quitlines, and cessation camps—and actively promoting their participation can be a practical approach.
Keywords : Lung cancer; Screening; Smoking cessation; Behavior change
References
  1. Statistics Korea. Cause-of-death statistics in 2022 [Internet]. 2023 [cited 2024 Sep 13].
  2. National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5): 395-409.
    Pubmed KoreaMed CrossRef
  3. Kvale PA, Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, et al. The Lung Screening Study: The National Cancer Institute’s Randomized Feasibility Study of Spiral CT versus Chest X-ray in Lung Cancer Screenin. CHEST. 2003; 124(4): 118S.
  4. Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, et al. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round. J Thorac Oncol. 2009; 4(5): 608-14.
    Pubmed CrossRef
  5. Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012; 21(3): 308-15.
    Pubmed CrossRef
  6. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization. J Thorac Oncol. 2015; 10(6): 890-6.
    Pubmed CrossRef
  7. Field JK, Duffy SW, Baldwin DR, Whynes DK, Devaraj A, Brain KE, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax. 2016; 71(2): 161-70.
    Pubmed KoreaMed CrossRef
  8. de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020; 382(6): 503-13.
    Pubmed CrossRef
  9. Jang SH, Sheen S, Kim HY, Yim HW, Park BY, Kim JW, et al. The Korean guideline for lung cancer screening. jkma. 2015;58(4):291-301.
    CrossRef
  10. Statistics Korea. National cancer screening rate [Internet]. 2023 [cited 2024 Sep 13].
  11. Lung cancer screening quality management center. Consultation rate after lung cancer screening in 2022 [Internet]. 2023 [cited 2024 Sep 28].
  12. Phs Guideline Update Panel L, Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008; 53(9): 1217-22.
  13. Kim Y, Lee J, Lee E, Lim J, Kim Y, Lee CT, et al. Strategies to Improve Smoking Cessation for Participants in Lung Cancer Screening Program: Analysis of Factors Associated with Smoking Cessation in Korean Lung Cancer Screening Project (K-LUCAS). Cancer Res Treat. 2024; 56(1): 92-103.
    Pubmed KoreaMed CrossRef
  14. Lee CM, Park SVH, Kim J, Oh B, Lee K, Kim Y, et al. Problems and Alternatives for Korea National Lung Cancer Screening Program for Smoking Cessation: Analysis of a Survey Involving Experts. JKSRNT. 2024; 15(2): 49-56.
    CrossRef
  15. Hahm SK, Kim HS, Lee ES. Smoking and Smoking Cessation in Women. Journal of the Korean Society for Research on Nicotine and Tobacco. 2022; 13(2): 35-42.
    CrossRef
  16. Cho H-J. Comparison of the risks of combustible cigarettes, e-cigarettes, and heated tobacco products. J Korean Med Assoc. 2020; 63(1): 96-104.
    CrossRef
  17. Pocket guide for consulting physicians on lung cancer screening results-assessment and follow-up of low-dose chest CT results: Korean association for lung cancer and National cancer center; 2021.
  18. Law MR, Wald NJ. Environmental tobacco smoke and ischemic heart disease. Prog Cardiovasc Dis. 2003; 46(1): 31-8.
    Pubmed CrossRef
  19. Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovic D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018; 360: j5855.
    Pubmed KoreaMed CrossRef
  20. Kim CY. Recent Trends of Research and Guidelines on Pharmacotherapy for Smoking Cessation. JKSRNT. 2022; 13(4): 107-15.
  21. Seo YB, Paek Y-J, Lee CM, Lee ES, Kang HS, Kim SY, et al. Korean Clinical Practice Guideline for Smoking Cessation Provided by the National Health Insurance Services. JKSRNT. 2023; 14(2): 41-8.
    CrossRef
  22. Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019; 4(4): CD013308.
    Pubmed KoreaMed CrossRef
  23. Leone FT, Zhang Y, Evers-Casey S, Evins AE, Eakin MN, Fathi J, et al. Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020; 202(2): e5-e31.
    Pubmed KoreaMed CrossRef
  24. McKee SA, Smith PH, Kaufman M, Mazure CM, Weinberger AH. Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis. Nicotine Tob Res. 2016; 18(5): 1002-11.
    Pubmed KoreaMed CrossRef
  25. McKee SA, Lawrence DE, Saccone P, McRae T, Anthenelli RM. Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial. Drug Alcohol Depend Rep. 2023; 8: 100177.
    Pubmed KoreaMed CrossRef